Indian neurosurgery simulator gets US patent through ICMR Patent Cell

Published On 2021-03-14 03:30 GMT   |   Update On 2021-03-14 03:30 GMT

New Delhi: Indian Council of Medical Research on Friday announced that India's indigenous neurosurgery simulator has been granted US Patent through the ICMR Patent Cell.

Taking to Twitter, ICMR said that the neuro-endoscope-box-trainer has been developed jointly by All India Institute of Medical Sciences (AIIMS) Delhi and Indian Institute of Technology (IIT) Delhi.

Also Read:Gujarat Govt to rope in private practitioners to deal with doctor shortage

"We are proud to announce that India's indigenous neurosurgery simulator, neuro-endoscope-box-trainer, granted US Patent through the ICMR Patent Cell. The simulator has been developed jointly by AIIMS Delhi and IIT Delhi," ICMR tweeted with a hashtag 'Make In India'.

Also Read:Dealing with Covid-19: Vice President Venkaiah Naidu values researchers for finding technological solutions

Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News